Targeting the DNA damage response via chemical exhaustion of replication protein A (RPA): Development and anti-cancer activity of small molecule RPA inhibitors

被引：0
|
作者：
Turchi, J. [1 ]
Gavande, N. [2 ]
Vandervere-Carozza, P. [2 ]
Pawelczak, K. [3 ]
机构：
[1] Indiana Univ Sch Med, Med & Biochem & Mol Biol, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Med, Indianapolis, IN 46202 USA
[3] NERx Biosci, Res, Indianapolis, IN USA
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
77 (PB-028
引用
收藏
页码：E33 / E33
页数：1
相关论文
共 38 条
  • [31] Small molecule targeting FOXM1 DNA binding domain exhibits anti-tumor activity in ovarian cancer
    Zaixin Zhang
    Si-tu Xue
    Yan Gao
    Yingwei Li
    Ziying Zhou
    Jing Wang
    Zhuorong Li
    Zhaojian Liu
    Cell Death Discovery, 8
  • [32] Small molecule targeting FOXM1 DNA binding domain exhibits anti-tumor activity in ovarian cancer
    Zhang, Zaixin
    Xue, Si-Tu
    Gao, Yan
    Li, Yingwei
    Zhou, Ziying
    Wang, Jing
    Li, Zhuorong
    Liu, Zhaojian
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [33] Anti-cancer activity of the HIV accessory molecule viral protein R (Vpr): Delivery as a DNA expression plasmid or biologically active peptides
    Muthumani, Karrupiah
    Lambert, Vance M.
    Kawalekar, Omkar
    Heller, Richard
    Kim, J. Joseph
    Weiner, David B.
    Ugen, Kenneth E.
    VACCINE, 2010, 28 (08) : 2005 - 2010
  • [34] Small Molecule Inhibitor Targeting CDT1/Geminin Protein Complex Promotes DNA Damage and Cell Death in Cancer Cells
    Karantzelis, Nikolaos
    Petropoulos, Michalis
    De Marco, Valeria
    Egan, David A.
    Fish, Alexander
    Christodoulou, Evangelos
    Will, David W.
    Lewis, Joe D.
    Perrakis, Anastassis
    Lygerou, Zoi
    Taraviras, Stavros
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [35] Characterization, targeting, and modulation of carbonic anhydrase IX activity for the development of small-molecule inhibitors to treat triple-negative breast cancer
    Mboge, Mam Y.
    Chen, Zhijuan
    Mahon, Brian P.
    Lamas, Nicole
    Tu, Shingkuang
    Carta, Fabrizio
    Superan, Claudiu T.
    McKenna, Robert
    Frost, Susan C.
    CANCER RESEARCH, 2016, 76
  • [36] A NRAS mRNA G-quadruplex structure-targeting small-molecule ligand reactivating DNA damage response in human cancer cells for combination therapy with clinical PI3K inhibitors
    Chan, Ka-Hin
    Zheng, Bo-Xin
    Leung, Alan Siu-Lun
    Long, Wei
    Zhao, Yuchen
    Zheng, Yingying
    Wong, Wing-Leung
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 279
  • [37] Gene Editing and Small Molecule Inhibitors of the RNA Binding Protein IGF2BP2/IMP2 Show its Potential as an Anti-Cancer Drug Target
    Chanda, Shilpee
    Lepikhov, Konstantin
    Dahlem, Charlotte
    Schymik, Hanna S.
    Hoppstaedter, Jessica
    Geber, An-Kristin
    Wagner, Konrad
    Kessler, Sonja M.
    Empting, Martin
    Kiemer, Alexandra K.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (01):
  • [38] DNA repair inhibition via targeting ATR activates cGAS/STING signaling, promotes anti-tumor immunity, and is a synthetic lethal strategy to augment immunotherapy response in preclinical models and clinical samples of small cell lung cancer
    Sen, Triparna
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (06)
1234